Dr. Sunil Kumar S. Reddy, MD

Dr. Reddy practices at Neuroscience Consultants in Tampa, Florida.

Dr. Reddy's NPI, 1952368433, was assigned on April 27, 2006. Dr. Reddy graduated from Gandhi Medical College in 1996. Dr. Reddy holds Florida license ME94714.

Dr. Reddy's primary practice is Neuroscience Consultants, at 2919 W Swann Ave, Tampa, FL 33609 in Hillsborough County. The practice phone is (786) 924-1311.

Dr. Reddy's primary practice is Neuroscience Consultants in Tampa, Florida. Dr. Reddy is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is First Choice Neurology. Dmand AI also links Dr. Reddy to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reddy practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Reddy's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Reddy is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Reddy's licenses on file in 3 states: Florida, Pennsylvania and North Dakota.

Dmand AI lists carpal tunnel syndrome, encephalopathy, epilepsy, essential tremor, hereditary polyneuropathy, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Reddy treats.

CMS data shows 16,396 Medicare services from Dr. Reddy across 14 procedure codes in 2024, for 455 Medicare patients. Medicare paid $200,884 for them.

CMS counts 455 Medicare patients who saw Dr. Reddy in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reddy's median patient age at 56, with 68% women.

In 2024, Dr. Reddy wrote 1,913 Medicare Part D claims for 301 patients. 87% of them were for generic drugs. CMS names the drug for 1,653 of them, across 51 drugs with 11 or more claims each, at $209,094 in total drug cost. In 2023, CMS named 1,552 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Reddy for performance year 2024, reported individually. Dr. Reddy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reddy as offering telehealth.

Dmand AI links Dr. Reddy to 1 clinical trial. Conditions studied include Alzheimer Disease and Tauopathies.

CMS Open Payments shows 1,667 general payments to Dr. Reddy from 80 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $2,296.

Dmand AI lists 1 award for Dr. Reddy, most recently CMS Stage 1 EHR in 2012.

Dr. Reddy graduated from Gandhi Medical College in 1996.

Dr. Reddy is in network with 11 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.